Parsing the Interferon Transcriptional Network and Its Disease Associations
暂无分享,去创建一个
Chun Jimmie Ye | N. Hacohen | A. Regev | S. Mostafavi | J. Casanova | Nicolas Chevrier | T. Raj | C. Benoist | P. D. Jager | D. Mathis | T. Feng | H. Yoshida | D. Moodley | H. LeBoité | K. Rothamel | Shen-Ying Zhang | Mark N. Lee | J. D. Clark | M. Hegen | J. Telliez | P. L. Jager | J. Clark
[1] AC Tose. Cell , 1993, Cell.
[2] M Aguet,et al. Functional role of type I and type II interferons in antiviral defense. , 1994, Science.
[3] L. Platanias,et al. Interferon alpha activates the tyrosine kinase Lyn in haemopoietic cells. , 1998, British journal of haematology.
[4] L. Platanias,et al. Interferon α activates the tyrosine kinase Lyn in haemopoietic cells , 1998 .
[5] Chilakamarti V. Ramana,et al. Biologic consequences of Stat1-independent IFN signaling , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[6] W. Dietrich,et al. A natural mutation in the Tyk2 pseudokinase domain underlies altered susceptibility of B10.Q/J mice to infection and autoimmunity , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[7] L. Platanias,et al. Mechanisms of type-I interferon signal transduction. , 2004, Journal of biochemistry and molecular biology.
[8] B. Beutler,et al. Type I interferons (alpha/beta) in immunity and autoimmunity. , 2005, Annual review of immunology.
[9] B. Beutler,et al. TYPE I INTERFERONS (/) IN IMMUNITY AND AUTOIMMUNITY , 2005 .
[10] G. Stark,et al. Complex modulation of cell type-specific signaling in response to type I interferons. , 2006, Immunity.
[11] Kevin Struhl,et al. The transition between transcriptional initiation and elongation in E. coli is highly variable and often rate limiting. , 2006, Molecular cell.
[12] J. Casanova,et al. Human Complete Stat-1 Deficiency Is Associated with Defective Type I and II IFN Responses In Vitro but Immunity to Some Low Virulence Viruses In Vivo1 , 2006, The Journal of Immunology.
[13] T. Maniatis,et al. Multiple functions of the IKK-related kinase IKKepsilon in interferon-mediated antiviral immunity. , 2007, Science.
[14] T. Maniatis,et al. Multiple Functions of the IKK-Related Kinase IKKε in Interferon-Mediated Antiviral Immunity , 2007, Science.
[15] D. Koller,et al. The Immunological Genome Project: networks of gene expression in immune cells , 2008, Nature Immunology.
[16] Zachary D. Smith,et al. Unbiased Reconstruction of a Mammalian Transcriptional Network Mediating Pathogen Responses , 2009 .
[17] A. Hoffmann,et al. A Unifying Model for the Selective Regulation of Inducible Transcription by CpG Islands and Nucleosome Remodeling , 2009, Cell.
[18] Gal Chechik,et al. Timing of Gene Expression Responses to Environmental Changes , 2009, J. Comput. Biol..
[19] Kai Wang,et al. Meta-analysis of Inter-species Liver Co-expression Networks Elucidates Traits Associated with Common Human Diseases , 2009, PLoS Comput. Biol..
[20] A. Nobel,et al. Finding large average submatrices in high dimensional data , 2009, 0905.1682.
[21] T. Flatt,et al. Transcriptome analysis reveals a major impact of JAK protein tyrosine kinase 2 (Tyk2) on the expression of interferon-responsive and metabolic genes , 2010, BMC Genomics.
[22] Virginia Pascual,et al. An Interferon-Inducible Neutrophil-Driven Blood Transcriptional Signature in Human Tuberculosis , 2010, Nature.
[23] Quaid Morris,et al. Fast integration of heterogeneous data sources for predicting gene function with limited annotation , 2010, Bioinform..
[24] Christopher B. Burge,et al. c-Myc Regulates Transcriptional Pause Release , 2010, Cell.
[25] Jacob T. Robinson,et al. Systematic Discovery of TLR Signaling Components Delineates Viral-Sensing Circuits , 2011, Cell.
[26] N. Nishimoto,et al. Underexpression of mitochondrial-DNA encoded ATP synthesis-related genes and DNA repair genes in systemic lupus erythematosus , 2011, Arthritis research & therapy.
[27] Peter O. Krutzik,et al. Structural Linkage between Ligand Discrimination and Receptor Activation by Type I Interferons , 2011, Cell.
[28] D. Fargo,et al. Regulating the regulators: the pervasive effects of Pol II pausing on stimulus-responsive gene networks. , 2012, Genes & development.
[29] E. Wherry,et al. Commensal bacteria calibrate the activation threshold of innate antiviral immunity. , 2012, Immunity.
[30] S. Forster. Interferon signatures in immune disorders and disease , 2012, Immunology and cell biology.
[31] J. Darnell,et al. The JAK-STAT pathway at twenty. , 2012, Immunity.
[32] Y. Lee,et al. Associations between PXK and TYK2 polymorphisms and systemic lupus erythematosus: a meta-analysis , 2012, Inflammation Research.
[33] John T. Lis,et al. Promoter-proximal pausing of RNA polymerase II: emerging roles in metazoans , 2012, Nature Reviews Genetics.
[34] D. Levy,et al. Constitutive type I interferon modulates homeostatic balance through tonic signaling. , 2012, Immunity.
[35] T. Beddoe,et al. Structural basis of a unique interferon-β signaling axis mediated via the receptor IFNAR1 , 2013, Nature Immunology.
[36] L. Ivashkiv,et al. Regulation of type I interferon responses , 2013, Nature Reviews Immunology.
[37] Howard Y. Chang,et al. Transposition of native chromatin for fast and sensitive epigenomic profiling of open chromatin, DNA-binding proteins and nucleosome position , 2013, Nature Methods.
[38] Mark E Flanagan,et al. Discovery and development of Janus kinase (JAK) inhibitors for inflammatory diseases. , 2014, Journal of medicinal chemistry.
[39] Daphne Koller,et al. Polarization of the Effects of Autoimmune and Neurodegenerative Risk Alleles in Leukocytes , 2014, Science.
[40] Manolis Kellis,et al. Common Genetic Variants Modulate Pathogen-Sensing Responses in Human Dendritic Cells , 2014, Science.
[41] Virginia Pascual,et al. Modular Transcriptional Repertoire Analyses of Adults With Systemic Lupus Erythematosus Reveal Distinct Type I and Type II Interferon Signatures , 2014, Arthritis & rheumatology.
[42] Chun Jimmie Ye,et al. Intersection of population variation and autoimmunity genetics in human T cell activation , 2014, Science.
[43] H. Valdez,et al. Analysis of Infections and All‐Cause Mortality in Phase II, Phase III, and Long‐Term Extension Studies of Tofacitinib in Patients With Rheumatoid Arthritis , 2014, Arthritis & rheumatology.
[44] C. Rice,et al. Interferon-stimulated genes: a complex web of host defenses. , 2014, Annual review of immunology.
[45] M. Crow,et al. Targeting of type I interferon in systemic autoimmune diseases. , 2015, Translational research : the journal of laboratory and clinical medicine.
[46] Maxwell R. Mumbach,et al. Dynamic profiling of the protein life cycle in response to pathogens , 2015, Science.
[47] Y. Crow,et al. Type I interferonopathies: mendelian type I interferon up-regulation. , 2015, Current opinion in immunology.